Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cerebrolysin as an Add-On Therapy to Standard Treatment of Posterior Circulation Stroke Secondary to Basilar Artery Occlusion

NCT06489925 is registered in ClinicalTrials.gov with University Hospital Sestre Milosrdnice as lead sponsor.

NCT NCT06489925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06489925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cerebrolysin as an Add-On Therapy to Standard Treatment of Posterior Circulation Stroke Secondary to Basilar Artery Occlusion
Lead sponsor
University Hospital Sestre Milosrdnice
Phase
Phase 1
Overall status
Unknown status
Start date
July 31, 2024
Completion date
May 31, 2026
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

basilar artery occlusion, posterior circulation brain infarction